In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ICCVAM Peer Review Meeting Evaluates Two In Vitro Cytotoxicity Tests

This article was originally published in The Rose Sheet

Executive Summary

Two in vitro cytotoxicity test methods are sufficient for use in a weight-of-evidence approach to determine the starting dose for acute oral in vivo toxicity testing, a scientific peer review panel concluded by consensus during a meeting of the Interagency Coordinating Committee on the Validation of Alternative Methods in Bethesda, Md. May 23

You may also be interested in...



ICCVAM Plans Next Steps Toward Reducing Animal Use In Toxicity Testing

Two federal agencies charged with reducing, refining and replacing the use of animals in U.S. toxicology testing have released a draft plan that, beginning in 2008, will guide their efforts over the next five years

ICCVAM Plans Next Steps Toward Reducing Animal Use In Toxicity Testing

Two federal agencies charged with reducing, refining and replacing the use of animals in U.S. toxicology testing have released a draft plan that, beginning in 2008, will guide their efforts over the next five years

ICCVAM Advisory Committee Addresses In Vitro Cytotoxicity Methods

The Scientific Advisory Committee on Alternative Toxicological Methods recommends additional assays be identified for inclusion in a battery testing approach for determining in vivo acute toxicity starting doses

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013964

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel